A review: Proteomics in nasopharyngeal carcinoma

International Journal of Molecular Sciences

Volumn 16, Issue 7, 2015, Pages 15497-15530

  Chen, Ze Tan ^a,b   Liang, Zhong Guo ^a,b   Zhu, Xiao Dong ^a,b  

^a Guangxi Cancer Institute   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Differentially expressed proteins; Mass spectrometry; Nasopharyngeal carcinoma; NPC (nasopharyngeal carcinoma); Proteomics; Two dimensional electrophoresis

Indexed keywords

ANNEXIN; CATHEPSIN; ENOLASE; HEAT SHOCK PROTEIN; KERATIN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PROHIBITIN; PROTEIN 14 3 3; RIBONUCLEOPROTEIN; STATHMIN; TRIOSEPHOSPHATE ISOMERASE; VIMENTIN; TUMOR MARKER;

GEL ELECTROPHORESIS; HUMAN; MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RADIOSENSITIVITY; REVIEW; TREATMENT RESPONSE; CARCINOMA; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOMARKERS, TUMOR; CARCINOMA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84939500922     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160715497     Document Type: Review

References (181)

1. Chia, W.K.; Teo, M.; Wang, W.W.; Lee, B.; Ang, S.F.; Tai, W.M.; Chee, C.L.; Ng, J.; Kan, R.; Lim, W.T.; et al. Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma. Mol. Ther. 2014, 22, 132-139.
2. Ho, J.H. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1978, 4, 182-198.
3. Hong Kong Cancer Registry. Available online: http://www3.ha.org.hk/cancereg/Statistics.html (accessed on 20 August 2013).
4. Zhou, G.; Zhai, Y.; Cui, Y.; Zhang, X.; Dong, X.; Yang, H.; He, Y.; Yao, K.; Zhang, H.; Zhi, L.; et al. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin. Cancer Res. 2007, 13, 2627-2633.
5. Zhou, X.; Cui, J.; Macias, V.; Kajdacsy-Balla, A.A.; Ye, H.; Wang, J.; Rao, P.N. The progress on genetic analysis of nasopharyngeal carcinoma. Comp. Funct. Genomics 2007, 2007, 57513.
6. Spano, J.P.; Busson, P.; Atlan, D.; Bourhis, J.; Pignon, J.P.; Esteban, C.; Armand, J.P. Nasopharyngeal carcinomas: An update. Eur. J. Cancer 2003, 39, 2121-2135.
7. Guo, X.; Cao, S.M.; Yu, J.K.; Hong, M.H.; Zhang, C.Q.; Li, N.W.; Xiang, Y.Q.; Qian, C.N.; Hu, X.; Min, H.Q.; et al. Distinct serumal proteomic patterns between ascending and descending types of loco-regionally advanced nasopharyngeal carcinoma assessed by surface enhanced laser desorption ionization and artificial neural network analyses. Chin. Med. J. 2005, 118, 1912-1917.
8. Du, C.; Ying, H.; Zhou, J.; Hu, C.; Zhang, Y. Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Int. J. Clin. Oncol. 2013, 18, 464-471.
9. Suarez, C.; Rodrigo, J.P.; Rinaldo, A.; Langendijk, J.A.; Shaha, A.R.; Ferlito, A. Current treatment options for recurrent nasopharyngeal cancer. Eur. Arch. Otorhinolaryngol. 2010, 267, 1811-1824.
10. Lee, A.W.; Ng, W.T.; Chan, L.L.; Hung, W.M.; Chan, C.C.; Sze, H.C.; Chan, O.S.; Chang, A.T.; Yeung, R.M. Evolution of treatment for nasopharyngeal cancer-Success and setback in the intensity-modulated radiotherapy era. Radiother. Oncol. 2014, 110, 377-384.
11. Li, G.P.; Wang, H.; Lai, Y.K.; Chen, S.C.; Lin, M.C.; Lu, G.; Zhang, J.F.; He, X.G.; Qian, C.N.; Kung, H.F. Proteomic profiling between CNE-2 and its strongly metastatic subclone S-18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma. Proteomics 2011, 11, 2911-2920.
12. Luftig, M. Heavy LIFting: Tumor promotion and radioresistance in NPC. J. Clin. Investig. 2013, 123, 4999-5001.
13. Cheng, J.C.; Chou, C.H.; Kuo, M.L.; Hsieh, C.Y. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3k/Akt/NF-κB signal transduction pathway. Oncogene 2006, 25, 7009-7018.
14. Yan, S.; Wang, Y.; Yang, Q.; Li, X.; Kong, X.; Zhang, N.; Yuan, C.; Yang, N.; Kong, B. Low-dose radiation-induced epithelial-mesenchymal transition through NF-κB in cervical cancer cells. Int. J. Oncol. 2013, 42, 1801-1806.
15. Li, G.; Liu, Y.; Su, Z.; Ren, S.; Zhu, G.; Tian, Y.; Qiu, Y. MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur. J. Cancer 2013, 49, 2596-2607.
16. Wu, D.; Ding, Y.; Wang, S.; Zhang, Q.; Liu, L. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. J. Pathol. 2008, 216, 167-175.
17. Liu, Y.; Su, Z.; Li, G.; Yu, C.; Ren, S.; Huang, D.; Fan, S.; Tian, Y.; Zhang, X.; Qiu, Y. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma. Int. J. Cancer 2013, 133, 671-679.
18. Qu, C.; Liang, Z.; Huang, J.; Zhao, R.; Su, C.; Wang, S.; Wang, X.; Zhang, R.; Lee, M.H.; Yang, H. Mir-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle 2012, 11, 785-796.
19. Hong, B.; Lui, V.W.; Hui, E.P.; Ng, M.H.; Cheng, S.H.; Sung, F.L.; Tsang, C.M.; Tsao, S.W.; Chan, A.T. Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation. Investig. New Drugs 2011, 29, 401-410.
20. Oh, E.T.; Park, M.T.; Song, M.J.; Lee, H.; Cho, Y.U.; Kim, S.J.; Chu, Y.C.; Choi, E.K.; Park, H.J. Radiation-induced angiogenic signaling pathway in endothelial cells obtained from normal and cancer tissue of human breast. Oncogene 2014, 33, 1229-1238.
21. Kim, S.H.; Joshi, K.; Ezhilarasan, R.; Myers, T.R.; Siu, J.; Gu, C.; Nakano-Okuno, M.; Taylor, D.; Minata, M.; Sulman, E.P.; et al. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Stem Cell Rep. 2015, 4, 226-238.
22. Zhou, Z.R.; Zhu, X.D.; Zhao, W.; Qu, S.; Su, F.; Huang, S.T.; Ma, J.L.; Li, X.Y. Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells. Oncol. Rep. 2013, 29, 2498-2506.
23. Li, X.M.; Huang, W.G.; Yi, H.; Cheng, A.L.; Xiao, Z.Q. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma. J. Cancer Res. Clin. Oncol. 2009, 135, 1763-1775.
24. Wasinger, V.C.; Cordwell, S.J.; Cerpa-Poljak, A.; Yan, J.X.; Gooley, A.A.; Wilkins, M.R.; Duncan, M.W.; Harris, R.; Williams, K.L.; Humphery-Smith, I. Progress with gene-product mapping of the mollicutes: Mycoplasma genitalium. Electrophoresis 1995, 16, 1090-1094.
25. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
26. Brunelle, J.L.; Green, R. One-dimensional SDS-polyacrylamide gel electrophoresis (1D SDS-PAGE). Methods Enzymol. 2014, 541, 151-159.
27. O'Farrell, P.H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
28. Hanash, S.M.; Strahler, J.R.; Neel, J.V.; Hailat, N.; Melhem, R.; Keim, D.; Zhu, X.X.; Wagner, D.; Gage, D.A.; Watson, J.T. Highly resolving two-dimensional gels for protein sequencing. Proc. Natl. Acad. Sci. USA 1991, 88, 5709-5713.
29. Magdeldin, S.; Enany, S.; Yoshida, Y.; Xu, B.; Zhang, Y.; Zureena, Z.; Lokamani, I.; Yaoita, E.; Yamamoto, T. Basics and recent advances of two dimensional-Polyacrylamide gel electrophoresis. Clin. Proteomics 2014, 11, 16.
30. Poillet, L.; Pernodet, N.; Boyer-Guittaut, M.; Adami, P.; Borg, C.; Jouvenot, M.; Delage-Mourroux, R.; Despouy, G. QSOX1 inhibits autophagic flux in breast cancer cells. PLoS ONE 2014, 9, e86641.
31. Wilkins, M.R.; Gasteiger, E.; Sanchez, J.C.; Bairoch, A.; Hochstrasser, D.F. Two-dimensional gel electrophoresis for proteome projects: The effects of protein hydrophobicity and copy number. Electrophoresis 1998, 19, 1501-1505.
32. Unlu, M.; Morgan, M.E.; Minden, J.S. Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
33. Friedman, D.B.; Hill, S.; Keller, J.W.; Merchant, N.B.; Levy, S.E.; Coffey, R.J.; Caprioli, R.M. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004, 4, 793-811.
34. Li, M.X.; Xiao, Z.Q.; Liu, Y.F.; Chen, Y.H.; Li, C.; Zhang, P.F.; Li, M.Y.; Li, F.; Peng, F.; Duan, C.J.; et al. Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue. J. Cell. Biochem. 2009, 106, 570-579.
35. Warren, C.M.; Geenen, D.L.; Helseth, D.L., Jr.; Xu, H.; Solaro, R.J. Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics. J. Proteomics 2010, 73, 1551-1561.
36. Petriz, B.A.; Gomes, C.P.; Rocha, L.A.; Rezende, T.M.; Franco, O.L. Proteomics applied to exercise physiology: A cutting-edge technology. J. Cell. Physiol. 2012, 227, 885-898.
37. Issaq, H.J.; Conrads, T.P.; Janini, G.M.; Veenstra, T.D. Methods for fractionation, separation and profiling of proteins and peptides. Electrophoresis 2002, 23, 3048-3061.
38. Gygi, S.P.; Rist, B.; Gerber, S.A.; Turecek, F.; Gelb, M.H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
39. Cho, E.A.; Kim, E.J.; Kwak, S.J.; Juhnn, Y.S. cAMP signaling inhibits radiation-induced ATM phosphorylation leading to the augmentation of apoptosis in human lung cancer cells. Mol. Cancer 2014, 13, 36.
40. Ong, S.E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D.B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
41. Holmberg, C.; Ghesquiere, B.; Impens, F.; Gevaert, K.; Kumar, J.D.; Cash, N.; Kandola, S.; Hegyi, P.; Wang, T.C.; Dockray, G.J.; et al. Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3. J. Proteome Res. 2013, 12, 3413-3422.
42. Colzani, M.; Schutz, F.; Potts, A.; Waridel, P.; Quadroni, M. Relative protein quantification by isobaric SILAC with immonium ion splitting (ISIS). Mol. Cell. Proteomics 2008, 7, 927-937.
43. Sury, M.D.; Chen, J.X.; Selbach, M. In vivo stable isotope labeling by amino acids in drosophila melanogaster. Methods Mol. Biol. 2014, 1188, 85-93.
44. Post, D.; Held, J.M.; Ketterer, M.R.; Phillips, N.J.; Sahu, A.; Apicella, M.A.; Gibson, B.W. Comparative analyses of proteins from haemophilus influenzae biofilm and planktonic populations using metabolic labeling and mass spectrometry. BMC Microbiol. 2014, 14, 2322.
45. Van Manen, H.J.; Lenferink, A.; Otto, C. Noninvasive imaging of protein metabolic labeling in single human cells using stable isotopes and raman microscopy. Anal. Chem. 2008, 80, 9576-9582.
46. Polson, C.; Cantone, J.L.; Wei, C.; Drexler, D.M.; Meredith, J.E., Jr. Stable isotope labeling by amino acids in cell culture-based liquid chromatography-mass spectrometry assay to measure microtubule dynamics in neuronal cell cultures. Anal. Biochem. 2014, 466, 65-71.
47. 13C]tyrosine. J. Biol. Chem. 2004, 279, 15805-15813.
48. Ross, P.L.; Huang, Y.N.; Marchese, J.N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; et al. Multiplexed protein quantitation in saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
49. Yang, L.; Jiang, T.; Fountain, J.C.; Scully, B.T.; Lee, R.D.; Kemerait, R.C.; Chen, S.; Guo, B. Protein profiles reveal diverse responsive signaling pathways in kernels of two maize inbred lines with contrasting drought sensitivity. Int. J. Mol. Sci. 2014, 15, 18892-18918.
50. Karas, M.; Hillenkamp, F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 1988, 60, 2299-2301.
51. Matsuura, K.; Murai, K.; Fukano, Y.; Takashina, H. Simultaneous determination of tiopronin and its metabolites in rat blood by LC-ESI-MS-MS using methyl acrylate for stabilization of thiol group. J. Pharm. Biomed. Anal. 2000, 22, 101-109.
52. Dalerba, P.; Dylla, S.J.; Park, I.K.; Liu, R.; Wang, X.; Cho, R.W.; Hoey, T.; Gurney, A.; Huang, E.H.; Simeone, D.M.; et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 2007, 104, 10158-10163.
53. Thomson, D.S.; Murphy, D.M. Laser-induced ion formation thresholds of aerosol particles in a vacuum. Appl. Opt. 1993, 32, 6818-6826.
54. Shevchenko, A.; Jensen, O.N.; Podtelejnikov, A.V.; Sagliocco, F.; Wilm, M.; Vorm, O.; Mortensen, P.; Shevchenko, A.; Boucherie, H.; Mann, M. Linking genome and proteome by mass spectrometry: Large-scale identification of yeast proteins from two dimensional gels. Proc. Natl. Acad. Sci. USA 1996, 93, 14440-14445.
55. Albalat, A.; Husi, H.; Stalmach, A.; Schanstra, J.P.; Mischak, H. Classical MALDI-MS vs. CE-based ESI-MS proteomic profiling in urine for clinical applications. Bioanalysis 2014, 6, 247-266.
56. Mischak, H.; Coon, J.J.; Novak, J.; Weissinger, E.M.; Schanstra, J.P.; Dominiczak, A.F. Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments. Mass Spectrom. Rev. 2009, 28, 703-724.
57. Schey, K.L.; Papac, D.I.; Knapp, D.R.; Crouch, R.K. Matrix-assisted laser desorption mass spectrometry of rhodopsin and bacteriorhodopsin. Biophys. J. 1992, 63, 1240-1243.
58. Rubakhin, S.S.; Jurchen, J.C.; Monroe, E.B.; Sweedler, J.V. Imaging mass spectrometry: Fundamentals and applications to drug discovery. Drug Discov. Today 2005, 10, 823-837.
59. Alexandrov, T. Maldi imaging mass spectrometry: Statistical data analysis and current computational challenges. BMC Bioinform. 2012, 13, S11.
60. Fels, D.R.; Ye, J.; Segan, A.T.; Kridel, S.J.; Spiotto, M.; Olson, M.; Koong, A.C.; Koumenis, C. Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. Cancer Res. 2008, 68, 9323-9330.
61. Liu, C. The application of SELDI-TOF-MS in clinical diagnosis of cancers. J. Biomed. Biotechnol. 2011, 2011, 245821.
62. Zheng, G.X.; Wang, C.X.; Qu, X.; Deng, X.M.; Deng, B.P.; Zhang, J. Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS. Exp. Oncol. 2006, 28, 282-287.
63. Jin, M.; Cataland, S.; Bissell, M.; Wu, H.M. A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry. J. Thromb. Haemost. 2006, 4, 333-338.
64. De Bock, M.; de Seny, D.; Meuwis, M.A.; Chapelle, J.P.; Louis, E.; Malaise, M.; Merville, M.P.; Fillet, M. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J. Biomed. Biotechnol. 2010, 2010, 906082.
65. Geng, X.; Wang, F.; Li, Y.G.; Zhu, G.P.; Zhang, W.M. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 2007, 26, 505-508.
66. Scarlett, C.J.; Saxby, A.J.; Nielsen, A.; Bell, C.; Samra, J.S.; Hugh, T.; Baxter, R.C.; Smith, R.C. Proteomic profiling of cholangiocarcinoma: Diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Hepatology 2006, 44, 658-666.
67. Lu, H.B.; Zhou, J.H.; Ma, Y.Y.; Lu, H.L.; Tang, Y.L.; Zhang, Q.Y.; Zhao, C.H. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn. J. Clin. Oncol. 2010, 40, 336-342.
68. Khan, G.H.; Galazis, N.; Docheva, N.; Layfield, R.; Atiomo, W. Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: A systematic review and biomarker database integration. Hum. Reprod. 2015, 30, 133-148.
69. Liu, Z.; Yuan, Z.; Zhao, Q. SELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects. PLoS ONE 2014, 9, e103276.
70. Tan, C.; Li, J.; Wang, J.; Xiang, Q.; Zhang, X.; Dong, L.; Shen, S.; Liang, S.; Li, G. Proteomic analysis of differential protein expression in human nasopharyngeal carcinoma cells induced by NAG7 transfection. Proteomics 2002, 2, 306-312.
71. Deng, L.; Jing, N.; Tan, G.; Zhou, M.; Zhan, F.; Xie, Y.; Cao, L.; Li, G. A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma. Genes Chromosom. Cancer 1998, 23, 21-25.
72. Jiang, P.; Gan, M.; Huang, H.; Shen, X.; Wang, S.; Yao, K. Proteome analysis of antiproliferative mechanism of 12-O-tetradecanoylphorbol 13-acetate on cultured nasopharyngeal carcinoma CNE2 cells. J. Proteome Res. 2005, 4, 599-605.
73. Jiang, P.Z.; Gan, M.; Huang, H.; Shen, X.M.; Wang, S.; Yao, K.T. Proteomics-based identification of proteins with altered expression induced by 12-O-tetradecanoylphorbol 13-acetate in nasopharyngeal carcinoma CNE2 cells. Acta Biochim. Biophys. Sin. 2005, 37, 97-106.
74. Wu, C.C.; Chien, K.Y.; Tsang, N.M.; Chang, K.P.; Hao, S.P.; Tsao, C.H.; Chang, Y.S.; Yu, J.S. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model. Proteomics 2005, 5, 3173-3182.
75. Sun, Y.; Yi, H.; Zhang, P.F.; Li, M.Y.; Li, C.; Li, F.; Peng, F.; Feng, X.P.; Yang, Y.X.; Yang, F.; et al. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett. 2007, 581, 131-139.
76. Sung, F.L.; Pang, R.T.; Ma, B.B.; Lee, M.M.; Chow, S.M.; Poon, T.C.; Chan, A.T. Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma. J. Proteome Res. 2006, 5, 3260-3267.
77. Yan, G.; Li, L.; Tao, Y.; Liu, S.; Liu, Y.; Luo, W.; Wu, Y.; Tang, M.; Dong, Z.; Cao, Y. Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology. Proteomics 2006, 6, 1810-1821.
78. Xiang, Y.L.; Yi, H.; Li, C.; Zhang, P.F.; Li, M.Y.; Chen, Z.C.; Xiao, Z.Q. Differential proteomic analysis of nasopharyngeal carcinoma cell lines 5-8F and 6-10B. J. Cent. South Univ. 2007, 32, 978-984.
79. Chan, C.M.; Wong, S.C.; Lam, M.Y.; Hui, E.P.; Chan, J.K.; Lo, E.S.; Cheuk, W.; Wong, M.C.; Tsao, S.W.; Chan, A.T. Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and β2-tubulin for nasopharyngeal carcinoma. Arch. Pathol. Lab. Med. 2008, 132, 675-683.
80. Tang, C.E.; Guan, Y.J.; Yi, B.; Li, X.H.; Liang, K.; Zou, H.Y.; Yi, H.; Li, M.Y.; Zhang, P.F.; Li, C.; et al. Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics. J. Proteome Res. 2010, 9, 6101-6111.
81. Chang, Y.H.; Wu, C.C.; Chang, K.P.; Yu, J.S.; Chang, Y.C.; Liao, P.C. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma. J. Proteome Res. 2009, 8, 5465-5474.
82. Chow, B.H.; Chua, D.T.; Sham, J.S.; Zhang, M.Y.; Chow, L.W.; Bi, J.; Ma, N.F.; Xie, D.; Loo, W.T.; Fung, J.M.; et al. Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors. Proteomics Clin. Appl. 2009, 3, 654-662.
83. Wu, C.C.; Hsu, C.W.; Chen, C.D.; Yu, C.J.; Chang, K.P.; Tai, D.I.; Liu, H.P.; Su, W.H.; Chang, Y.S.; Yu, J.S. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 2010, 9, 1100-1117.
84. Chang, K.P.; Wu, C.C.; Chen, H.C.; Chen, S.J.; Peng, P.H.; Tsang, N.M.; Lee, L.Y.; Liu, S.C.; Liang, Y.; Lee, Y.S.; et al. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: Potential usage of cystatin A for predicting nodal stage and poor prognosis. Proteomics 2010, 10, 2644-2660.
85. Feng, X.P.; Yi, H.; Li, M.Y.; Li, X.H.; Yi, B.; Zhang, P.F.; Li, C.; Peng, F.; Tang, C.E.; Li, J.L.; et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res. 2010, 70, 3450-3462.
86. Ruan, L.; Wang, G.L.; Chen, Y.; Yi, H.; Tang, C.E.; Zhang, P.F.; Li, M.Y.; Li, C.; Peng, F.; Li, J.L.; et al. Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology. Med. Oncol. 2010, 27, 1407-1414.
87. Liu, H.P.; Wu, C.C.; Kao, H.Y.; Huang, Y.C.; Liang, Y.; Chen, C.C.; Yu, J.S.; Chang, Y.S. Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration. Mol. Cell. Proteomics 2011, 10, M900641MCP900200.
88. Huang, W.G.; Cheng, A.L.; Chen, Z.C.; Peng, F.; Zhang, P.F.; Li, M.Y.; Li, F.; Li, J.L.; Li, C.; Yi, H.; et al. Targeted proteomic analysis of 14-3-3σ in nasopharyngeal carcinoma. Int. J. Biochem. Cell Biol. 2010, 42, 137-147.
89. Ruan, L.; Li, X.H.; Wan, X.X.; Yi, H.; Li, C.; Li, M.Y.; Zhang, P.F.; Zeng, G.Q.; Qu, J.Q.; He, Q.Y.; et al. Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics. Proteome Sci. 2011, 9, 35.
90. Zeng, G.Q.; Yi, H.; Li, X.H.; Shi, H.Y.; Li, C.; Li, M.Y.; Zhang, P.F.; Feng, X.P.; Wan, X.X.; Qu, J.Q.; et al. Identification of the proteins related to p53-mediated radioresponse in nasopharyngeal carcinoma by proteomic analysis. J. Proteomics 2011, 74, 2723-2733.
91. Feng, X.; Zhang, J.; Chen, W.N.; Ching, C.B. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: Identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis. J. Proteomics 2011, 74, 567-576.
92. Zhang, B.; Qu, J.Q.; Xiao, L.; Yi, H.; Zhang, P.F.; Li, M.Y.; Hu, R.; Wan, X.X.; He, Q.Y.; Li, J.H.; et al. Identification of heat shock protein 27 as a radioresistance-related protein in nasopharyngeal carcinoma cells. J. Cancer Res. Clin. Oncol. 2012, 138, 2117-2125.
93. Liu, J.; Zhan, X.; Li, M.; Li, G.; Zhang, P.; Xiao, Z.; Shao, M.; Peng, F.; Hu, R.; Chen, Z. Mitochondrial proteomics of nasopharyngeal carcinoma metastasis. BMC Med. Genomics 2012, 5, 62.
94. Liu, Z.; Chen, C.; Yang, H.; Zhang, Y.; Long, J.; Long, X.; Fang, W. Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma. Proteomics 2012, 12, 3416-3425.
95. Tang, S.; Huang, W.; Zhong, M.; Yin, L.; Jiang, H.; Hou, S.; Gan, P.; Yuan, Y. Identification keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines. J. Proteomics 2012, 75, 2352-2360.
96. Wang, L.J.; Hsu, C.W.; Chen, C.C.; Liang, Y.; Chen, L.C.; Ojcius, D.M.; Tsang, N.M.; Hsueh, C.; Wu, C.C.; Chang, Y.S. Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes. Mol. Cell. Proteomics 2012, 11, 1230-1244.
97. Bartsch, H.; Ohshima, H.; Pignatelli, B.; Calmels, S. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 1992, 2, 272-277.
98. Li, Y.; Liu, N.; Huang, D.; Zhang, Z.; Peng, Z.; Duan, C.; Tang, X.; Tan, G.; Yan, G.; Mei, W.; et al. Proteomic analysis on N,N′-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells. BMC Biochem. 2012, 13, 25.
99. Li, L.; Huang, S.; Zhu, X.; Zhou, Z.; Liu, Y.; Qu, S.; Guo, Y. Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis. Cancer Biother. Radiopharm. 2013, 28, 380-384.
100. Lin, S.J.; Chang, K.P.; Hsu, C.W.; Chi, L.M.; Chien, K.Y.; Liang, Y.; Tsai, M.H.; Lin, Y.T.; Yu, J.S. Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma. J. Proteomics 2013, 94, 186-201.
101. Yan, G.R.; Tan, Z.; Wang, Y.; Xu, M.L.; Yu, G.; Li, Y.; He, Q.Y. Quantitative proteomics characterization on the antitumor effects of isodeoxyelephantopin against nasopharyngeal carcinoma. Proteomics 2013, 13, 3222-3232.
102. Wu, Z.; Weng, D.; Li, G. Quantitative proteome analysis of overexpressed cripto-1 tumor cell reveals 14-3-3γ as a novel biomarker in nasopharyngeal carcinoma. J. Proteomics 2013, 83, 26-36.
103. Huang, D.; Li, Y.; Liu, N.; Zhang, Z.; Peng, Z.; Duan, C.; Tang, X.; Tan, G.; Yan, G.; Tang, F. Identification of novel signaling components in N,N′-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma by quantitative phosphoproteomics. BMC Cancer 2014, 14, 243.
104. Yang, X.; Dai, W.; Kwong, D.L.; Szeto, C.Y.; Wong, E.H.; Ng, W.T.; Lee, A.W.; Ngan, R.K.; Yau, C.C.; Tung, S.Y.; et al. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. Int. J. Cancer 2015, 136, E127-E135.
105. Niedobitek, G.; Agathanggelou, A.; Barber, P.; Smallman, L.A.; Jones, E.L.; Young, L.S. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J. Pathol. 1993, 170, 457-461.
106. Ma, B.B.; Poon, T.C.; To, K.F.; Zee, B.; Mo, F.K.; Chan, C.M.; Ho, S.; Teo, P.M.; Johnson, P.J.; Chan, A.T. Prognostic significance of tumor angiogenesis, ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma-A prospective study. Head Neck 2003, 25, 864-872.
107. Sung, F.L.; Poon, T.C.; Hui, E.P.; Ma, B.B.; Liong, E.; To, K.F.; Huang, D.P.; Chan, A.T. Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells. In Vivo 2005, 19, 237-245.
108. Liu, T.; Ding, Y.; Xie, W.; Li, Z.; Bai, X.; Li, X.; Fang, W.; Ren, C.; Wang, S.; Hoffman, R.M.; et al. An imageable metastatic treatment model of nasopharyngeal carcinoma. Clin. Cancer Res. 2007, 13, 3960-3967.
109. Li, X.; Hu, R.; Qu, J.; He, Q.; Chen, Y.; Li, J.; Ye, X.; Xiang, Y.; Yi, H. Identification of nm23-H1 as a metastatic suppressor and prognostic factor in nasopharyngeal carcinoma by proteomic analysis. J. Cent. South Univ. 2012, 37, 17-26.
110. Hofmann, U.B.; Eggert, A.A.; Blass, K.; Brocker, E.B.; Becker, J.C. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res. 2003, 63, 8221-8225.
111. Ford, N.A.; Devlin, K.L.; Lashinger, L.M.; Hursting, S.D. Deconvoluting the obesity and breast cancer link: Secretome, soil and seed interactions. J. Mammary Gland Biol. Neoplasia 2013, 18, 267-275.
112. To, E.W.; Chan, K.C.; Leung, S.F.; Chan, L.Y.; To, K.F.; Chan, A.T.; Johnson, P.J.; Lo, Y.M. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin. Cancer Res. 2003, 9, 3254-3259.
113. Gonze, D.; Abou-Jaoude, W. The goodwin model: Behind the hill function. PLoS ONE 2013, 8, e69573.
114. Liu, H.P.; Wu, C.C.; Chang, Y.S. PRA1 promotes the intracellular trafficking and NF-κB signaling of EBV latent membrane protein 1. EMBO J. 2006, 25, 4120-4130.
115. Qian, C.N.; Berghuis, B.; Tsarfaty, G.; Bruch, M.; Kort, E.J.; Ditlev, J.; Tsarfaty, I.; Hudson, E.; Jackson, D.G.; Petillo, D.; et al. Preparing the "soil": The primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res. 2006, 66, 10365-10376.
116. Liu, Z.; Li, X.; He, X.; Jiang, Q.; Xie, S.; Yu, X.; Zhen, Y.; Xiao, G.; Yao, K.; Fang, W. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: Its potential role and preliminarily functional mechanism. Int. J. Cancer 2011, 128, 2562-2571.
117. Tan, G.; Tang, X.; Huang, D.; Li, Y.; Liu, N.; Peng, Z.; Zhang, Z.; Duan, C.; Lu, J.; Yan, G.; et al. Dinitrosopiperazine-mediated phosphorylated-proteins are involved in nasopharyngeal carcinoma metastasis. Int. J. Mol. Sci. 2014, 15, 20054-20071.
118. Strizzi, L.; Bianco, C.; Normanno, N.; Salomon, D. Cripto-1: A multifunctional modulator during embryogenesis and oncogenesis. Oncogene 2005, 24, 5731-5741.
119. Wu, Z.; Li, G.; Wu, L.; Weng, D.; Li, X.; Yao, K. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. BMC Cancer 2009, 9, 315.
120. Juan, H.F.; Chen, J.H.; Hsu, W.T.; Huang, S.C.; Chen, S.T.; Yi-Chung Lin, J.; Chang, Y.W.; Chiang, C.Y.; Wen, L.L.; Chan, D.C.; et al. Identification of tumor-associated plasma biomarkers using proteomic techniques: From mouse to human. Proteomics 2004, 4, 2766-2775.
121. Baumann, H.; Gauldie, J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol. Biol. Med. 1990, 7, 147-159.
122. Moshage, H. Cytokines and the hepatic acute phase response. J. Pathol. 1997, 181, 257-266.
123. Wu, C.C.; Peng, P.H.; Chang, Y.T.; Huang, Y.S.; Chang, K.P.; Hao, S.P.; Tsang, N.M.; Yeh, C.T.; Chang, Y.S.; Yu, J.S. Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation. Proteomics 2008, 8, 3605-3620.
124. Tang, F.Q.; Duan, C.J.; Huang, D.M.; Wang, W.W.; Xie, C.L.; Meng, J.J.; Wang, L.; Jiang, H.Y.; Feng, D.Y.; Wu, S.H.; et al. HSP70 and mucin 5B: Novel protein targets of N,N′-dinitrosopiperazineinduced nasopharyngeal tumorigenesis. Cancer Sci. 2009, 100, 216-224.
125. Hsieh, C.K.; Li, C.C.; Min, H.C.; Chang, F.L.; Li, P.K. Clinical analysis of 1000 cases of nasopharyngeal carcinoma with particular reference to early diagnosis and clinical types of late cases. Chin. Med. J. 1965, 84, 767-780.
126. Romualdi, C.; Campanaro, S.; Campagna, D.; Celegato, B.; Cannata, N.; Toppo, S.; Valle, G.; Lanfranchi, G. Pattern recognition in gene expression profiling using DNA array: A comparative study of different statistical methods applied to cancer classification. Hum. Mol. Genet. 2003, 12, 823-836.
127. Doustjalali, S.R.; Yusof, R.; Govindasamy, G.K.; Bustam, A.Z.; Pillay, B.; Hashim, O.H. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J. Med. Investig. 2006, 53, 20-28.
128. Xiao, Z.Q.; Chen, Y.; Yi, B.; Li, M.Y.; Zhang, P.F.; Yi, H.; Duan, C.J.; Li, C.; Li, J.L.; Tang, C.E.; et al. Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis. Proteomics Clin. Appl. 2007, 1, 688-698.
129. Engwegen, J.Y.; Gast, M.C.; Schellens, J.H.; Beijnen, J.H. Clinical proteomics: Searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci. 2006, 27, 251-259.
130. Wei, Y.S.; Zheng, Y.H.; Liang, W.B.; Zhang, J.Z.; Yang, Z.H.; Lv, M.L.; Jia, J.; Zhang, L. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Cancer 2008, 112, 544-551.
131. Li, F.; Xiao, Z.; Zhang, P.; Li, J.; Li, M.; Feng, X.; Guan, Y.; Chen, Z. A reference map of human nasopharyngeal squamous carcinoma proteome. Int. J. Oncol. 2007, 30, 1077-1088.
132. Cheng, A.L.; Huang, W.G.; Chen, Z.C.; Zhang, P.F.; Li, M.Y.; Li, F.; Li, J.L.; Li, C.; Yi, H.; Peng, F.; et al. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J. Proteome Res. 2008, 7, 2415-2426.
133. Cheng, A.L.; Huang, W.G.; Chen, Z.C.; Peng, F.; Zhang, P.F.; Li, M.Y.; Li, F.; Li, J.L.; Li, C.; Yi, H.; et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin. Cancer Res. 2008, 14, 435-445.
134. Chen, Y.; Ouyang, G.L.; Yi, H.; Li, M.Y.; Zhang, P.F.; Li, C.; Li, J.L.; Liu, Y.F.; Chen, Z.C.; Xiao, Z.Q. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. J. Proteome Res. 2008, 7, 5254-5262.
135. Granovsky, A.E.; Rosner, M.R. Raf kinase inhibitory protein: A signal transduction modulator and metastasis suppressor. Cell Res. 2008, 18, 452-457.
136. Liao, Q.L.; Chen, X.D.; Zhao, L.; Ding, Y.Q. Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: A study with two-dimensional electrophoresis and MALDI-TOF-MS. J. South Med. Univ. 2008, 28, 154-158.
137. Li, M.X.; Xiao, Z.Q.; Chen, Y.H.; Peng, F.; Li, C.; Zhang, P.F.; Li, M.Y.; Li, F.; Duan, C.J.; Li, D.J.; et al. Proteomic analysis of the stroma-related proteins in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues. Med. Oncol. 2010, 27, 134-144.
138. Chen, Y.; Tang, C.E.; Ouyang, G.L.; Ruan, L.; Li, M.Y.; Zhang, P.F.; Li, C.; Yi, H.; Peng, F.; Li, J.L.; et al. Identification of RKIP as a differentially tyrosine-phosphorylated protein in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues by phosphoproteomic approach. Med. Oncol. 2009, 26, 463-470.
139. Huang, Y.J.; Xuan, C.; Zhang, B.B.; Liao, M.; Deng, K.F.; He, M.; Zhao, J.M. SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J. Exp. Clin. Cancer Res. 2009, 28, 85.
140. Cao, S.M.; Yu, J.K.; Chen, Q.Y.; Li, N.W.; Xiang, Y.Q.; Qian, C.N.; Hu, X.; Zhang, C.Q.; Xie, D.; Guo, X. Detection of nasopharyngeal carcinoma using surface-enhanced laser desorption and ionization mass spectrometry profiles of the serum proteome. Chin. J. Cancer 2010, 29, 721-728.
141. Tang, C.E.; Tan, T.; Li, C.; Chen, Z.C.; Ruan, L.; Wang, H.H.; Su, T.; Zhang, P.F.; Xiao, Z.Q. Identification of galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis. Oncol. Rep. 2010, 24, 495-500.
142. Xiao, Z.; Li, G.; Chen, Y.; Li, M.; Peng, F.; Li, C.; Li, F.; Yu, Y.; Ouyang, Y.; Xiao, Z.; et al. Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. J. Histochem. Cytochem. 2010, 58, 517-527.
143. Huang, X.W.; Zhou, W.; Chen, J.; Chu, H.Q.; Xiao, C.W.; Hua, X.Y.; Zhang, P.; Li, H.Q.; Cui, Y.H. A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma. Chin. J. Otorhinolaryngol. Head Neck Surg. 2011, 46, 509-512.
144. Tao, Y.L.; Liu, Z.G.; Xia, Y.F.; Yi, W. Establishment of a specific serum proteomic profile model of nasopharyngeal carcinoma by MALDI-TOF MS. Chin. J. Oncol. 2011, 33, 188-191.
145. Su, H.F.; Zhang, X.B.; Fang, M.; He, Q.C.; Li, W.F.; Wu, S.X. Protein microarray analysis on changes in protein phosphorylation in recurrent nasopharyngeal carcinoma. Zhonghua Yi Xue Za Zhi 2011, 91, 3219-3222. (In Chinese)
146. Peng, P.H.; Wu, C.C.; Liu, S.C.; Chang, K.P.; Chen, C.D.; Chang, Y.T.; Hsu, C.W.; Chang, Y.S.; Yu, J.S. Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J. Proteomics 2011, 74, 744-757.
147. Pan, C.; Tao, Y.; Zhao, M.; Li, W.; Huang, Z.; Gao, J.; Wu, Y.; Yu, J.; Wu, P.; Xia, Y.; et al. Comparative serum proteomic analysis involving liver organ-specific metastasis-associated proteins of nasopharyngeal carcinoma. Exp. Ther. Med. 2012, 3, 1055-1061.
148. Tao, Y.L.; Li, Y.; Gao, J.; Liu, Z.G.; Tu, Z.W.; Li, G.; Xu, B.Q.; Niu, D.L.; Jiang, C.B.; Yi, W.; et al. Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads. J. Cell. Biochem. 2012, 113, 2268-2278.
149. Wu, P.; Zhang, H.; Qi, L.; Tang, Q.; Tang, Y.; Xie, Z.; Lv, Y.; Zhao, S.; Jiang, W. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Oncol. Rep. 2012, 27, 987-994.
150. Li, M.; Li, C.; Li, D.; Xie, Y.; Shi, J.; Li, G.; Guan, Y.; Li, M.; Zhang, P.; Peng, F.; et al. Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma. Clin. Exp. Metastasis 2012, 29, 865-877.
151. Su, F.; Zhu, X.; Liang, Z.; Li, L.; Qu, S.; Liang, X.; Wang, Q.; Liang, S.; Chen, L. Analysis of serum proteome profiles in nasopharyngeal carcinoma with different radiosensitivity. Clin. Transl. Oncol. 2014, 16, 147-152.
152. Yang, J.; Zhou, M.; Zhao, R.; Peng, S.; Luo, Z.; Li, X.; Cao, L.; Tang, K.; Ma, J.; Xiong, W.; et al. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis. J. Proteomics 2014, 109, 162-175.
153. De Corte, V.; van Impe, K.; Bruyneel, E.; Boucherie, C.; Mareel, M.; Vandekerckhove, J.; Gettemans, J. Increased importin-β-dependent nuclear import of the actin modulating protein CapG promotes cell invasion. J. Cell Sci. 2004, 117, 5283-5292.
154. Chen, M.; Sinha, M.; Luxon, B.A.; Bresnick, A.R.; O'Connor, K.L. Integrin α6β4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J. Biol. Chem. 2009, 284, 1484-1494.
155. Guo, Y.; Zhu, X.D.; Qu, S.; Li, L.; Su, F.; Li, Y.; Huang, S.T.; Li, D.R. Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Int. J. Oncol. 2012, 40, 85-92.
156. Guo, S.Y.; Zhu, X.D.; Ge, L.Y.; Qu, S.; Li, L.; Su, F.; Guo, Y. RNAi-mediated knockdown of the C-Jun gene sensitizes radioresistant human nasopharyngeal carcinoma cell line CNE-2R to radiation. Oncol. Rep. 2015, 33, 1155-1160.
157. Polioudaki, H.; Agelaki, S.; Chiotaki, R.; Politaki, E.; Mavroudis, D.; Matikas, A.; Georgoulias, V.; Theodoropoulos, P.A. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer 2015, 15, 399.
158. White, R.A.; Neiman, J.M.; Reddi, A.; Han, G.; Birlea, S.; Mitra, D.; Dionne, L.; Fernandez, P.; Murao, K.; Bian, L.; et al. Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J. Clin. Investig. 2013, 123, 4390-4404.
159. Kang, H.J.; Koh, K.H.; Yang, E.; You, K.T.; Kim, H.J.; Paik, Y.K.; Kim, H. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics 2006, 6, 1151-1157.
160. Bhardwaj, A.; Ganesan, N.; Tachibana, K.; Rajapakshe, K.; Albarracin, C.T.; Gunaratne, P.H.; Coarfa, C.; Bedrosian, I. Annexin A1 preferentially predicts poor prognosis of basal-like breast cancer patients by activating mTOR-S6 signaling. PLoS ONE 2015, 10, e0127678.
161. Tas, F.; Tilgen Yasasever, C.; Karabulut, S.; Tastekin, D.; Duranyildiz, D. Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables. Biomed. Pharm. 2015, 69, 237-241.
162. Duncan, R.; Carpenter, B.; Main, L.C.; Telfer, C.; Murray, G.I. Characterisation and protein expression profiling of annexins in colorectal cancer. Br. J. Cancer 2008, 98, 426-433.
163. Gomez-Monterrey, I.; Campiglia, P.; Bertamino, A.; Aquino, C.; Sala, M.; Grieco, P.; Dicitore, A.; Vanacore, D.; Porta, A.; Maresca, B.; et al. A novel quinone-based derivative (DTNQ-Pro) induces apoptotic death via modulation of heat shock protein expression in Caco-2 cells. Br. J. Pharm. 2010, 160, 931-940.
164. Gunaldi, M.; Afsar, C.U.; Okuturlar, Y.; Gedikbasi, A.; Kocoglu, H.; Kural, A.; Akarsu, C.; Gunduz, U.; Tiken, E.E. Elevated serum levels of heat shock protein 70 are associated with breast cancer. Tohoku J. Exp. Med. 2015, 236, 97-102.
165. Chen, Y.; Chen, C.; Ma, C.; Sun, S.; Zhang, J.; Sun, Y. Expression of heat-shock protein gp96 in gallbladder cancer and its prognostic clinical significance. Int. J. Clin. Exp. Pathol. 2015, 8, 1946-1953.
166. Yang, W.; Dicker, D.T.; Chen, J.; El-Deiry, W.S. CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2. Cell Cycle 2008, 7, 670-682.
167. Radovic, S.; Doric, M.; Hukic, A.; Babic, M.; Kuskunovic, S.; Spahovic, N. Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma. Bosn. J. Basic Med. Sci. 2013, 13, 72-77.
168. Liu, J.; Yang, Y.F.; Fu, X.L.; Yu, Y.; Gu, L. Significance of TIMP-1 and nm-23 expressions in HER-2-positive breast cancer. Chin. J. Oncol. 2012, 34, 600-604.
169. Zhang, H.; Fu, T.; McGettigan, S.; Kumar, S.; Liu, S.; Speicher, D.; Schuchter, L.; Xu, X. IL-8 and cathepsin B as melanoma serum biomarkers. Int. J. Mol. Sci. 2011, 12, 1505-1518.
170. Huang, Z.; Tan, N.; Guo, W.; Wang, L.; Li, H.; Zhang, T.; Liu, X.; Xu, Q.; Li, J.; Guo, Z. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis. PLoS ONE 2014, 9, e91596.
171. Paul, S.; Dansithong, W.; Kim, D.; Rossi, J.; Webster, N.J.; Comai, L.; Reddy, S. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J. 2006, 25, 4271-4283.
172. Yang, M.; Li, L.; Wang, J.; Gao, T.; Sun, Y.; Li, H.; Tong, X.; Ouyang, Y. Heterogeneous nuclear ribonucleoproteins (hnRNPs) and human transformer-2-β1 (hTra2-β1)-regulated estrogen receptor-α improves prognosis of endometrial cancer. Eur. J. Gynaecol. Oncol. 2014, 35, 701-707.
173. Bracha, S.; McNamara, M.; Hilgart, I.; Milovancev, M.; Medlock, J.; Goodall, C.; Wickramasekara, S.; Maier, C.S. A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine. Anal. Biochem. 2014, 455, 41-47.
174. Phueaouan, T.; Chaiyawat, P.; Netsirisawan, P.; Chokchaichamnankit, D.; Punyarit, P.; Srisomsap, C.; Svasti, J.; Champattanachai, V. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer. Oncol. Rep. 2013, 30, 2929-2936.
175. Song, Y.; Luo, Q.; Long, H.; Hu, Z.; Que, T.; Zhang, X.; Li, Z.; Wang, G.; Yi, L.; Liu, Z.; et al. Correction: α-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. Mol. Cancer 2015, 13, 235.
176. Fu, Q.F.; Liu, Y.; Fan, Y.; Hua, S.N.; Qu, H.Y.; Dong, S.W.; Li, R.L.; Zhao, M.Y.; Zhen, Y.; Yu, X.L.; et al. α-Enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway. J. Hematol. Oncol. 2015, 8, 22.
177. Marsh, L.; Shah, K. A novel inhibitor of mammalian triosephosphate isomerase found by an in silico approach. Int. J. Med. Chem. 2014, 2014, 469125.
178. Lin, X.; Liao, Y.; Xie, J.; Liu, S.; Su, L.; Zou, H. Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines. Cancer Biother. Radiopharm. 2014, 29, 376-386.
179. Kathiria, A.S.; Neumann, W.L.; Rhees, J.; Hotchkiss, E.; Cheng, Y.; Genta, R.M.; Meltzer, S.J.; Souza, R.F.; Theiss, A.L. Prohibitin attenuates colitis-associated tumorigenesis in mice by modulating p53 and STAT3 apoptotic responses. Cancer Res. 2012, 72, 5778-5789.
180. Van Doorn, W.G.; Beers, E.P.; Dangl, J.L.; Franklin-Tong, V.E.; Gallois, P.; Hara-Nishimura, I.; Jones, A.M.; Kawai-Yamada, M.; Lam, E.; Mundy, J.; et al. Morphological classification of plant cell deaths. Cell Death Differ. 2011, 18, 1241-1246.
181. Yamasaki, T.; Seki, N.; Yamada, Y.; Yoshino, H.; Hidaka, H.; Chiyomaru, T.; Nohata, N.; Kinoshita, T.; Nakagawa, M.; Enokida, H. Tumor suppressive MicroRNA138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Int. J. Oncol. 2012, 41, 805-817.